1
Q
In Vivo Labeling tagging efficiency
A
65-85% Non specific SN PYP sensitazation, renal exrectino of Tc99MO4
2
Q
Modified In vivo-Invitro tagging efficiency
A
85-90% non specific SN-PYP sensitization
3
Q
In Vitro Ultratag tagging efficiency
A
95%
4
Q
LVEF
A
ED CTS- ES CTS/ ED cts- BKG
5
Q
MUGA cardiotoxic definition
A
Change in >10% from baseline AND Drop of <50%
6
Q
Doxirubicin MUGA protocol
A
Baseline within first 100mg/m2 in all
next one at 250-300 mg/ms
next at 450 mg/m2 (or 400 is high risk)
next muga PRIOR TO EACH DOSE >450 mg/m2
7
Q
if baseline MUGA <50% in Doxorubicin
A
must do muga before each dose
8
Q
If baseline MUGA <50% definition of cardiotoxic
A
LVEF >10% from Baseline OR OR OR LV EF<30%
Nuclear Boards
flashcards
Decks in class (6)
# Cards
